Jupiter Topco’s Bristol-Myers Squibb BMY Stock Holding History

Jupiter Topco’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.6M	Buy	+704,213	New	+$40.4M	0.02%	485

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jupiter Topco's BMY Position: Q2 2026 in Review

Jupiter Topco opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 704,213 shares worth $40.6M. The stake represents 0.02% of the portfolio and ranks #485 among its holdings.

2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Jupiter Topco held 704,213 shares of Bristol-Myers Squibb worth $40.6M as of Q2 2026.
Bristol-Myers Squibb was a new Jupiter Topco position in Q2 2026.
Bristol-Myers Squibb made up 0.02% of Jupiter Topco's portfolio in Q2 2026, its #485 holding.
2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.